메뉴 건너뛰기




Volumn 28, Issue 4, 2008, Pages 443-446

The effect of targeted magnetic nanopaticles on hepatoma and the expression of bcl-2/bax protein

Author keywords

Bax; Bcl 2; Cell line; Liver neoplasms; Magnetic nanoparticles, 5 Fu

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG CARRIER; FLUOROURACIL; NANOPARTICLE; PROTEIN BAX; PROTEIN BCL 2;

EID: 49749086431     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0415-z     Document Type: Article
Times cited : (2)

References (24)
  • 1
    • 70049094380 scopus 로고    scopus 로고
    • Target distribution of magnetic albumin nanoparticles containing adriamycin in model of transplanted liver cancer in rats
    • 9
    • Gong L S, Zhang Y D, Liu S. Target distribution of magnetic albumin nanoparticles containing adriamycin in model of transplanted liver cancer in rats. Chin J Hepatobiliary Surg (Chinese), 2003,9(9):543-546
    • (2003) Chin J Hepatobiliary Surg (Chinese) , vol.9 , pp. 543-546
    • Gong, L.S.1    Zhang, Y.D.2    Liu, S.3
  • 2
    • 0033559933 scopus 로고    scopus 로고
    • Estimates of the worldwide incidence of 25 major cancers in 1990
    • Parkin D M, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer, 1999, 80:827-841
    • (1999) Int J Cancer , vol.80 , pp. 827-841
    • Parkin, D.M.1    Pisani, P.2    Ferlay, J.3
  • 3
    • 0034781817 scopus 로고    scopus 로고
    • Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential
    • Tang Z Y, Sun F X, Tian J et al. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J Gastroenterol, 2001,7:597-601
    • (2001) World J Gastroenterol , vol.7 , pp. 597-601
    • Tang, Z.Y.1    Sun, F.X.2    Tian, J.3
  • 4
    • 0028212137 scopus 로고
    • Recurrence after resection of fetoprotein-positive hepatocellular carcinoma
    • Zhou X D, Tang Z Y, Yu Y Q et al. Recurrence after resection of fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol, 1994,120:369-373
    • (1994) J Cancer Res Clin Oncol , vol.120 , pp. 369-373
    • Zhou, X.D.1    Tang, Z.Y.2    Yu, Y.Q.3
  • 5
    • 0029841614 scopus 로고    scopus 로고
    • Indications for and effectiveness of a second hepatic resection for recurrent hepatocellular carcinoma
    • Shuto T, Kinoshita H, Hirohashi K et al. Indications for and effectiveness of a second hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology, 1996,43:932-937
    • (1996) Hepatogastroenterology , vol.43 , pp. 932-937
    • Shuto, T.1    Kinoshita, H.2    Hirohashi, K.3
  • 6
    • 0036046677 scopus 로고    scopus 로고
    • Molecular targets for prevention of hepatocellular carcinoma
    • Blum H E. Molecular targets for prevention of hepatocellular carcinoma. Dig Dis, 2002,20:81-90
    • (2002) Dig Dis , vol.20 , pp. 81-90
    • Blum, H.E.1
  • 7
    • 1642375906 scopus 로고    scopus 로고
    • The efficacy of the combination therapy of 5-fluorouracil cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors
    • 4
    • Kogure T, Ueno Y, Iwasaki T et al. The efficacy of the combination therapy of 5-fluorouracil cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors. Cancer Chemother Pharmacol, 2004,53(4):296-304
    • (2004) Cancer Chemother Pharmacol , vol.53 , pp. 296-304
    • Kogure, T.1    Ueno, Y.2    Iwasaki, T.3
  • 8
    • 12444293395 scopus 로고    scopus 로고
    • Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma
    • 2C
    • Tainok H, Tsuiji A, Morita S et al. Combination chemotherapy with continuous 5-fluorouracil and low-dose cisplatin infusion for advanced hepatocellular carcinoma. Anticancer Res, 2003,23(2C):1891-1897
    • (2003) Anticancer Res , vol.23 , pp. 1891-1897
    • Tainok, H.1    Tsuiji, A.2    Morita, S.3
  • 9
    • 0035742390 scopus 로고    scopus 로고
    • Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma
    • 5
    • Pohl J, Zuna I, Stremmel W et al. Systemic chemotherapy with epirubicin for treatment of advanced or multifocal hepatocellular carcinoma. Chemotherapy, 2001,47(5):359-65
    • (2001) Chemotherapy , vol.47 , pp. 359-65
    • Pohl, J.1    Zuna, I.2    Stremmel, W.3
  • 10
    • 12444335256 scopus 로고    scopus 로고
    • Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma
    • 2C
    • Murata K, Shiraki K, Kawakita T et al. Low-dose chemotherapy of cisplatin and 5-fluorouracil or doxorubicin via implanted fusion port for unresectable hepatocellular carcinoma. Anticancer Res, 2003,23(2C):1719-1722
    • (2003) Anticancer Res , vol.23 , pp. 1719-1722
    • Murata, K.1    Shiraki, K.2    Kawakita, T.3
  • 11
    • 0036218413 scopus 로고    scopus 로고
    • Intrahepatic arterial infusion of chemotherapy: Clinical results
    • 2
    • Dizon D S, Kemeny N E. Intrahepatic arterial infusion of chemotherapy: clinical results. Semin Oncol, 2002,29(2):126-135
    • (2002) Semin Oncol , vol.29 , pp. 126-135
    • Dizon, D.S.1    Kemeny, N.E.2
  • 12
    • 34447535945 scopus 로고    scopus 로고
    • Target distribution of magnetic nanoparticle containing drug in vivo and its therapeutical efficiency for liver cancer
    • 6
    • Zhang Y D, Gong L S, Pan Y F et al. Target distribution of magnetic nanoparticle containing drug in vivo and its therapeutical efficiency for liver cancer. China Journal of Medical Engineering, 2003,11(6):18-21
    • (2003) China Journal of Medical Engineering , vol.11 , pp. 18-21
    • Zhang, Y.D.1    Gong, L.S.2    Pan, Y.F.3
  • 13
    • 49749116889 scopus 로고    scopus 로고
    • Nanotechnology and treatment and prevention of tumor
    • 2
    • Lv D P, Li L J, Liu X Q. Nanotechnology and treatment and prevention of tumor. Chin J Prac Surg (Chinese), 2002,22(2):126-128
    • (2002) Chin J Prac Surg (Chinese) , vol.22 , pp. 126-128
    • Lv, D.P.1    Li, L.J.2    Liu, X.Q.3
  • 14
    • 0030035871 scopus 로고    scopus 로고
    • Systemic and adjuvant therapy for patients with pancreatic carcinoma
    • 3Suppl
    • Clark J W, Glicksman A S, Wanebo H J. Systemic and adjuvant therapy for patients with pancreatic carcinoma. Cancer, 1996,78(3 Suppl):688-693
    • (1996) Cancer , vol.78 , pp. 688-693
    • Clark, J.W.1    Glicksman, A.S.2    Wanebo, H.J.3
  • 15
    • 33745987641 scopus 로고    scopus 로고
    • Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner
    • 2
    • Yan X, Fraser M, Qiu Q et al. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol Oncol, 2006,102(2):348-355
    • (2006) Gynecol Oncol , vol.102 , pp. 348-355
    • Yan, X.1    Fraser, M.2    Qiu, Q.3
  • 16
    • 22144463566 scopus 로고    scopus 로고
    • The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells
    • 2-3
    • Grivicich I, Regner A, da Rocha A B et al. The irinotecan/5-fluorouracil combination induces apoptosis and enhances manganese superoxide dismutase activity in HT-29 human colon carcinoma cells. Chemotherapy, 2005,51(2-3):93-102
    • (2005) Chemotherapy , vol.51 , pp. 93-102
    • Grivicich, I.1    Regner, A.2    Da Rocha, A.B.3
  • 17
    • 0028329172 scopus 로고
    • Apoptosis its significance in cancer and cancer therapy
    • 8
    • Kerr J F, Winterford C M, Harmon B V. Apoptosis its significance in cancer and cancer therapy. Cancer, 1994, 73(8):2013-2026
    • (1994) Cancer , vol.73 , pp. 2013-2026
    • Kerr, J.F.1    Winterford, C.M.2    Harmon, B.V.3
  • 18
    • 0028809209 scopus 로고
    • Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
    • 2
    • Yang E, Zha J, Jockel J et al. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 1995,80(2):285-291
    • (1995) Cell , vol.80 , pp. 285-291
    • Yang, E.1    Zha, J.2    Jockel, J.3
  • 19
    • 0029671360 scopus 로고    scopus 로고
    • The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated
    • 1
    • Gottschalk A R, Boise L H, Oltvai Z N et al. The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated. Cell Death Differ, 1996,3(1):113-118
    • (1996) Cell Death Differ , vol.3 , pp. 113-118
    • Gottschalk, A.R.1    Boise, L.H.2    Oltvai, Z.N.3
  • 20
    • 0036333713 scopus 로고    scopus 로고
    • C-Myc functionally cooperates with Bax to induce apoptosis
    • 17
    • Juin P, Hunt A, Littlewood T et al. c-Myc functionally cooperates with Bax to induce apoptosis. Mol Cell Biol, 2002,22(17):6158-6169
    • (2002) Mol Cell Biol , vol.22 , pp. 6158-6169
    • Juin, P.1    Hunt, A.2    Littlewood, T.3
  • 21
    • 49749112990 scopus 로고    scopus 로고
    • Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis
    • 29
    • Yao H, Li P, Venters B J et al. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem, 2008,283(29):20060-20068
    • (2008) J Biol Chem , vol.283 , pp. 20060-20068
    • Yao, H.1    Li, P.2    Venters, B.J.3
  • 22
    • 0033083990 scopus 로고    scopus 로고
    • Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
    • 3
    • Keane M M, Ettenberg S A, Nau M M et al. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res, 1999,59(3):734-741
    • (1999) Cancer Res , vol.59 , pp. 734-741
    • Keane, M.M.1    Ettenberg, S.A.2    Nau, M.M.3
  • 23
    • 47049099431 scopus 로고    scopus 로고
    • TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer
    • 4
    • Wang Z, Song W, Aboukameel A et al. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer. Int J Cancer. 2008,123(4):958-966
    • (2008) Int J Cancer , vol.123 , pp. 958-966
    • Wang, Z.1    Song, W.2    Aboukameel, A.3
  • 24
    • 23844504107 scopus 로고    scopus 로고
    • Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis
    • 30
    • Duan X X, Ou J S, Li Y et al. Dynamic expression of apoptosis-related genes during development of laboratory hepatocellular carcinoma and its relation to apoptosis. World J Gastroenterol, 2005,11(30):4740-4744
    • (2005) World J Gastroenterol , vol.11 , pp. 4740-4744
    • Duan, X.X.1    Ou, J.S.2    Li, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.